Infectious Diseases
Latest News
Does screening kids with acute sinusitis symptoms for bacterial infection cut unnecessary antibiotic use?
If antibiotic use was limited to children with H. influenzae or S. pneumoniae in their nasopharynx at the time of diagnosis, antibiotic use would...
Latest News
Partial immunization leaves children and communities at risk, study finds
The strongest association with not completing the vaccine series was moving across state lines and not having insurance.
Conference Coverage
Low HIV levels linked to ‘almost zero’ risk of sexual transmission
“This [finding] provides a powerful opportunity to help destigmatize HIV, promote the benefits of adhering to antiretroviral therapy, and support...
Latest News
CDC offers guidance on RSV vaccines for adults
Rather than targeting all adults 60 and over, the decision calls for consideration of a patients’ risk for disease and their characteristics,...
Latest News
FDA approves cantharidin for molluscum contagiosum
The development marks the first FDA-approved treatment for the condition.
Practice Alert
Screening for hepatitis B: Where the CDC and USPSTF diverge
The CDC recently issued guidance on screening for hepatitis B infection. Here’s a look at how (and why) these recommendations differ from those of...
Latest News
Case report describes pediatric RIME triggered by norovirus
The study author says the incidence of RIME appears to be increasing, although its true epidemiology is unknown.
Conference Coverage
Infection-related chronic illness: A new paradigm for research and treatment
Researchers are looking to build a common research agenda for infection-related chronic illnesses to “understand the epidemiology and pathogenesis...
Conference Coverage
Research points toward combination therapy for Lyme and improved diagnostics
Lyme disease researchers are investigating combination therapy to address “persister” bacteria and diagnostic tests that test directly for the...
News from the FDA/CDC
Pneumococcal vaccine label adds injection-site risk
Reports of injection-site necrosis emerged after the vaccine had been approved by the FDA and was administered to a large, diverse, real-world...
News from the FDA/CDC
FDA approves RSV monoclonal antibody for all infants
The long-acting antibody is given as a single intramuscular injection.